RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.23B
AUM Growth
+$101M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
96
New
Increased
Reduced
Closed

Top Buys

1
+$23.6M
2
+$23M
3
+$18.1M
4
MRK icon
Merck
MRK
+$15.1M
5
RPRX icon
Royalty Pharma
RPRX
+$12.5M

Top Sells

1
+$50.1M
2
+$25.9M
3
+$23.4M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$20.6M
5
IMMU
Immunomedics Inc
IMMU
+$18.8M

Sector Composition

1 Healthcare 97.59%
2 Industrials 0.53%
3 Communication Services 0%
4 Consumer Discretionary 0%
5 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$2.88M 0.23%
265,000
77
$2.87M 0.23%
+564,400
78
$1.87M 0.15%
+156,700
79
$1.73M 0.14%
+125,000
80
$1.52M 0.12%
+3,000
81
$1.41M 0.12%
+35,000
82
$966K 0.08%
+300,000
83
$750K 0.06%
3,750
84
– –
-37,000
85
– –
-15,000
86
– –
-8,322
87
– –
-144,604
88
– –
-2,974
89
– –
-29,164
90
– –
-40,000
91
– –
-2,381
92
– –
-40,466
93
– –
-61,500
94
– –
-190,000
95
– –
-166,961
96
– –
-221,351
1 2 3
4